ImmuneID Funding & Investors
Boston, MA
ImmuneID is a precision immunology company using its proprietary platform to simultaneously identify and therapeutically target millions of antibody interactions that drive immune diseases.
immuneidrx.comTotal Amount Raised: $67,000,000
ImmuneID Funding Rounds
Series A
$50,000,000
Series A Investors
Alta PartnersLongwood FundTekla Capital ManagementArch Venture PartnersAlexandria Venture InvestmentsSection 32IQT (In-Q-Tel)XfundRedwood Capital InvestmentsSeries Unknown
$17,000,000
Series Unknown Investors
Longwood FundXfundIQT (In-Q-Tel)Arch Venture PartnersPitango
Funding info provided by Diffbot.